These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1656551)

  • 21. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
    Ohmura E; Okada M; Onoda N; Kamiya Y; Murakami H; Tsushima T; Shizume K
    Cancer Res; 1990 Jan; 50(1):103-7. PubMed ID: 2152769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
    Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
    Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different action of ovine GH on porcine theca and granulosa cells proliferation and insulin-like growth factors I- and II-stimulated estradiol production.
    Kołodziejczyk J; Gregoraszczuk EL; Leibovich H; Gertler A
    Reprod Biol; 2001 Jul; 1(1):33-41. PubMed ID: 14666173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
    Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
    Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.
    Daly RJ; Harris WH; Wang DY; Darbre PD
    Cell Growth Differ; 1991 Sep; 2(9):457-64. PubMed ID: 1661135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor binding and mitogenic effects of insulin and insulinlike growth factors I and II for human myeloid leukemic cells.
    Pepe MG; Ginzton NH; Lee PD; Hintz RL; Greenberg PL
    J Cell Physiol; 1987 Nov; 133(2):219-27. PubMed ID: 2960684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin-like growth factor II binding and action in human fetal fibroblasts.
    Conover CA; Rosenfeld RG; Hintz RL
    J Cell Physiol; 1987 Dec; 133(3):560-6. PubMed ID: 2961773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma.
    Manara MC; Landuzzi L; Nanni P; Nicoletti G; Zambelli D; Lollini PL; Nanni C; Hofmann F; García-Echeverría C; Picci P; Scotlandi K
    Clin Cancer Res; 2007 Feb; 13(4):1322-30. PubMed ID: 17317844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I and type II insulin-like growth factor receptors and their function in human Ewing's sarcoma cells.
    van Valen F; Winkelmann W; Jürgens H
    J Cancer Res Clin Oncol; 1992; 118(4):269-75. PubMed ID: 1315779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling.
    Garofalo C; Manara MC; Nicoletti G; Marino MT; Lollini PL; Astolfi A; Pandini G; López-Guerrero JA; Schaefer KL; Belfiore A; Picci P; Scotlandi K
    Oncogene; 2011 Jun; 30(24):2730-40. PubMed ID: 21278796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a new human THY-1 related antigen in Ewing's sarcoma and peripheral neuroectodermal tumors.
    Hamilton G; Havel M; Mallinger R
    Immunol Lett; 1989 Sep; 22(3):205-9. PubMed ID: 2572544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor.
    Sabharwal P; Varma S
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2663-9. PubMed ID: 8675594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. A potential autocrine growth factor.
    Yee D; Favoni RE; Lebovic GS; Lombana F; Powell DR; Reynolds CP; Rosen N
    J Clin Invest; 1990 Dec; 86(6):1806-14. PubMed ID: 2174908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines.
    Baier TG; Jenne EW; Blum W; Schönberg D; Hartmann KK
    Leuk Res; 1992 Aug; 16(8):807-14. PubMed ID: 1326686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-I-dependent growth and in vitro chemosensitivity of Ewing's sarcoma and peripheral primitive neuroectodermal tumour cell lines.
    Hofbauer S; Hamilton G; Theyer G; Wollmann K; Gabor F
    Eur J Cancer; 1993; 29A(2):241-5. PubMed ID: 8380698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of monomeric acrylic embedding media on the antigenicity of two epitopes of the MIC2-encoded Ewing's sarcoma cell membrane antigen.
    Hamilton G; Hamilton B; Mallinger R
    Histochemistry; 1992; 97(1):87-94. PubMed ID: 1377663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell mediated immunity in human osteogenic sarcoma.
    Agashe SS; Nair PN; Rao RS; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):61-6. PubMed ID: 1058832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.